Veru to Present Two Abstracts at ObesityWeek 2025
(NASDAQ:VERU), MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the presentation of two abstracts at ObesityWeek 2025 taking place November 4-7, 2025, in Atlanta, Georgia. Poster presentation name: Enobosarm Reduced […]